DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

8603	Companies
140901	Keywords
76848	Articles
75292	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 05/16/2024 at 22:30, 10 months 22 days ago

DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2024
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2024 avec toutes les résolutions adoptées. La société se concentre sur le traitement des allergies alimentaires et autres affections immunologiques non satisfaites

Résultats Assemblée Générale Mixte DBV Technologies Allergies Alimentaires Options De Traitement
BRIEF

published on 05/09/2024 at 22:35, 10 months 29 days ago

DBV Technologies announces its participation in two investor conferences in May

DBV Technologies Food Allergy JMP Life Sciences HC Wainwright BioConnect Conference Webcast
BRIEF

published on 05/09/2024 at 22:35, 10 months 29 days ago

DBV Technologies annonce sa participation à deux conférences investisseurs en mai

DBV Technologies Allergies Alimentaires JMP Sciences De La Vie H.C. Wainwright BioConnect Webdiffusion Conférence
PRESS RELEASE

published on 05/09/2024 at 22:30, 10 months 29 days ago

DBV Technologies to Participate in Upcoming Investor Conferences
DBV Technologies to participate in two upcoming investor conferences in May, presenting its clinical-stage biopharmaceutical developments. Learn more about their innovative treatment options

Investor Conferences Biopharmaceutical DBV Technologies Food Allergies Immunologic Conditions
PRESS RELEASE

published on 05/09/2024 at 22:30, 10 months 29 days ago

Participation de DBV Technologies aux conférences investisseurs en mai
DBV Technologies participera aux conférences investisseurs en mai pour présenter les options de traitement des allergies alimentaires et conditions immunologiques, notamment avec sa plateforme Viaskin. Détails des événements disponibles sur le site web

Traitement Conférences Investisseurs DBV Technologies Allergies Alimentaires Viaskin
BRIEF

published on 05/07/2024 at 22:35, 11 months ago

DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités

Résultats Financiers DBV Technologies Efficacité Viaskin Peanut Nomination Affaires Réglementaires Évolution Trésorerie Essai Clinique VITESSE
BRIEF

published on 05/07/2024 at 22:35, 11 months ago

DBV Technologies publishes its financial results for the first quarter of 2024 and provides an update on its activities

DBV Technologies Financial Results Effectiveness Viaskin Peanut Regulatory Affairs Appointment Cash Flow Evolution VITESSE Clinical Trial
PRESS RELEASE

published on 05/07/2024 at 22:30, 11 months ago

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
DBV Technologies reports Q1 2024 financial results and business update, with VITESSE enrollment progress, appointment of Chief Regulatory Officer, and $101.5 million cash balance

Financial Results Q1 2024 DBV Technologies VITESSE Enrollment Chief Regulatory Officer
PRESS RELEASE

published on 05/07/2024 at 22:30, 11 months ago

DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités
DBV Technologies publie ses résultats financiers du premier trimestre 2024, recrutement en bonne voie pour VITESSE, nomination de Robert Pietrusko comme Directeur des Affaires Règlementaires

Résultats Financiers Affaires Réglementaires DBV Technologies VITESSE Robert Pietrusko

Accesswire

Published on 04/08/2025 at 15:30, 1 hour 34 minutes ago

Southern Energy Announces Completion of Equity Financings to Ramp Up Liquids-Rich Gas Production in a Premium-Priced U.S. Natural Gas Market
Published on 04/08/2025 at 15:10, 1 hour 54 minutes ago

Focus Universal Inc. to Participate in Centri Capital Conference
Published on 04/08/2025 at 15:10, 1 hour 54 minutes ago

NCMI Applauds JOGMEC investment into Rare Earth Separation and Provides Update on Accelerated Value Engineering at Lofdal Dysprosium-Terbium Project
Published on 04/08/2025 at 15:00, 2 hours 4 minutes ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Published on 04/08/2025 at 15:00, 2 hours 4 minutes ago

Xebra Brands Reaffirms North American Strategy Following U.S. Tariff Clarity

View all ACCESSWIRE

EQS Group

Published on 04/08/2025 at 16:48, 16 minutes ago

Annual General Meeting V-ZUG: Shareholders approve all proposals
Published on 04/08/2025 at 15:51, 1 hour 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 04/08/2025 at 15:50, 1 hour 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 04/08/2025 at 15:50, 1 hour 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Published on 04/08/2025 at 15:49, 1 hour 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc

Les Echos

Published on 04/08/2025 at 11:00, 6 hours 4 minutes ago

CNP Assurances devient le 1er assureur français au classement ESG de Sustainalytics
Published on 04/08/2025 at 11:00, 6 hours 4 minutes ago

CNP Assurances becomes the 1st French insurer in the Sustainalytics ESG ranking
Published on 04/08/2025 at 08:30, 8 hours 34 minutes ago

Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 31/03/2025 tot 04/04/2025
Published on 04/08/2025 at 08:30, 8 hours 34 minutes ago

Cie du Bois Sauvage : Rachat d’actions propres – semaine du 31/03/2025 au 04/04/2025
Published on 04/08/2025 at 08:30, 8 hours 34 minutes ago

Cie du Bois Sauvage: Buy back of own shares – week from 31/03/2025 to 04/04/2025

View all LES ECHOS COMFI WIRE